Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blood. Thrombopoietin--at last.

× No keyword cloud information.

12 in total

1. Stem-cell factor regulates the expression of cyclin A and retinoblastoma gene product in the growth and differentiation pathway of human megakaryocytic cells.

Authors: E Shimizu; Y Takahashi; A Shinohara; Y Yamamoto; S Yoshida; A Yamamoto; S Sone; Y Takaue; T Ogura
Journal: J Cancer Res Clin Oncol Date: 1996 Impact factor: 4.553

Review 2. Facilitating oligonucleotide delivery: helping antisense deliver on its promise.

Authors: A M Gewirtz; C A Stein; P M Glazer
Journal: Proc Natl Acad Sci U S A Date: 1996-04-16 Impact factor: 11.205

Review 3. Haemopoietic growth factors.

Authors: N J Ketley; A C Newland
Journal: Postgrad Med J Date: 1997-04 Impact factor: 2.401

Review 4. Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents.

Authors: R L Basser; C G Begley
Journal: Int J Hematol Date: 2001-12 Impact factor: 2.490

5. Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis.

Authors: V R Deutsch; A Eldor; T Olson; V Barak; M Pick; A Nagler
Journal: Med Oncol Date: 1996-03 Impact factor: 3.064

Review 6. Platelet bioreactor: accelerated evolution of design and manufacture.

Authors: Jonathan N Thon; Brad J Dykstra; Lea M Beaulieu
Journal: Platelets Date: 2017-01-23 Impact factor: 3.862

7. Effects of Recombinant Human Megakaryocyte Growth and Development Factor (rHuMGDF) on Platelet Production, Platelet Aggregation, and Thrombosis.

Authors:
Journal: J Thromb Thrombolysis Date: 1998 Impact factor: 2.300

Review 8. Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid/megakaryocytic progenitor cell.

Authors: Thalia Papayannopoulou; Kenneth Kaushansky
Journal: Exp Hematol Date: 2016-01-08 Impact factor: 3.084

9. Recombinant haemopoietic growth factors in the newborn--will they be useful?

Authors: C A Wardrop; B M Holland
Journal: Eur J Pediatr Date: 1995 Impact factor: 3.183

Review 10. Clinical indications for thrombopoietin and thrombopoietin-receptor agonists.

Authors: Bernhard Wörmann
Journal: Transfus Med Hemother Date: 2013-09-11 Impact factor: 3.747